Logo image of EVISO.MI

EVISO SPA (EVISO.MI) Stock Fundamental Analysis

BIT:EVISO - Euronext Milan - IT0005430936 - Common Stock - Currency: EUR

10.38  +0.04 (+0.39%)

Fundamental Rating

6

Overall EVISO gets a fundamental rating of 6 out of 10. We evaluated EVISO against 15 industry peers in the Electric Utilities industry. EVISO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EVISO shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year EVISO was profitable.
In the past year EVISO had a positive cash flow from operations.
EVISO.MI Yearly Net Income VS EBIT VS OCF VS FCFEVISO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.80%, EVISO is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
EVISO has a better Return On Equity (29.92%) than 93.33% of its industry peers.
EVISO's Return On Invested Capital of 24.37% is amongst the best of the industry. EVISO outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 29.92%
ROIC 24.37%
ROA(3y)0.8%
ROA(5y)N/A
ROE(3y)3.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVISO.MI Yearly ROA, ROE, ROICEVISO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20

1.3 Margins

EVISO has a worse Profit Margin (2.10%) than 80.00% of its industry peers.
In the last couple of years the Profit Margin of EVISO has grown nicely.
EVISO has a worse Operating Margin (3.16%) than 80.00% of its industry peers.
In the last couple of years the Operating Margin of EVISO has grown nicely.
EVISO's Gross Margin of 6.00% is on the low side compared to the rest of the industry. EVISO is outperformed by 86.67% of its industry peers.
In the last couple of years the Gross Margin of EVISO has remained more or less at the same level.
Industry RankSector Rank
OM 3.16%
PM (TTM) 2.1%
GM 6%
OM growth 3Y6.8%
OM growth 5YN/A
PM growth 3Y7.51%
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5YN/A
EVISO.MI Yearly Profit, Operating, Gross MarginsEVISO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 2 4 6

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EVISO is creating value.
Compared to 1 year ago, EVISO has less shares outstanding
EVISO has a better debt/assets ratio than last year.
EVISO.MI Yearly Shares OutstandingEVISO.MI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
EVISO.MI Yearly Total Debt VS Total AssetsEVISO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

EVISO has an Altman-Z score of 6.02. This indicates that EVISO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.02, EVISO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
EVISO has a debt to FCF ratio of 0.90. This is a very positive value and a sign of high solvency as it would only need 0.90 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.90, EVISO belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
EVISO has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
EVISO has a better Debt to Equity ratio (0.25) than 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 0.9
Altman-Z 6.02
ROIC/WACC2.92
WACC8.34%
EVISO.MI Yearly LT Debt VS Equity VS FCFEVISO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 1.07 indicates that EVISO should not have too much problems paying its short term obligations.
EVISO has a Current ratio of 1.07. This is comparable to the rest of the industry: EVISO outperforms 60.00% of its industry peers.
EVISO has a Quick Ratio of 1.07. This is a normal value and indicates that EVISO is financially healthy and should not expect problems in meeting its short term obligations.
EVISO has a better Quick ratio (1.07) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 1.07
EVISO.MI Yearly Current Assets VS Current LiabilitesEVISO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

9

3. Growth

3.1 Past

EVISO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 183.30%, which is quite impressive.
The Earnings Per Share has been growing by 55.59% on average over the past years. This is a very strong growth
EVISO shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.05%.
EVISO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 43.61% yearly.
EPS 1Y (TTM)183.3%
EPS 3Y55.59%
EPS 5YN/A
EPS Q2Q%49.45%
Revenue 1Y (TTM)51.05%
Revenue growth 3Y43.61%
Revenue growth 5YN/A
Sales Q2Q%55.53%

3.2 Future

Based on estimates for the next years, EVISO will show a very strong growth in Earnings Per Share. The EPS will grow by 36.67% on average per year.
Based on estimates for the next years, EVISO will show a very strong growth in Revenue. The Revenue will grow by 26.97% on average per year.
EPS Next Y56.54%
EPS Next 2Y47.41%
EPS Next 3Y36.67%
EPS Next 5YN/A
Revenue Next Year45.79%
Revenue Next 2Y34.22%
Revenue Next 3Y26.97%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
EVISO.MI Yearly Revenue VS EstimatesEVISO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
EVISO.MI Yearly EPS VS EstimatesEVISO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.52, the valuation of EVISO can be described as expensive.
Based on the Price/Earnings ratio, EVISO is valued expensively inside the industry as 80.00% of the companies are valued cheaper.
Compared to an average S&P500 Price/Earnings ratio of 26.35, EVISO is valued quite expensively.
EVISO is valuated rather expensively with a Price/Forward Earnings ratio of 21.67.
66.67% of the companies in the same industry are cheaper than EVISO, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EVISO to the average of the S&P500 Index (22.19), we can say EVISO is valued inline with the index average.
Industry RankSector Rank
PE 41.52
Fwd PE 21.67
EVISO.MI Price Earnings VS Forward Price EarningsEVISO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EVISO is valued a bit more expensive than 73.33% of the companies in the same industry.
EVISO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. EVISO is cheaper than 73.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 25.9
EV/EBITDA 20.94
EVISO.MI Per share dataEVISO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

EVISO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EVISO's earnings are expected to grow with 36.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y47.41%
EPS Next 3Y36.67%

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.44%, EVISO is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.41, EVISO's dividend is way lower than its industry peers. On top of this 80.00% of the companies listed in the same industry pay a better dividend than EVISO!
Compared to an average S&P500 Dividend Yield of 2.40, EVISO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

17.81% of the earnings are spent on dividend by EVISO. This is a low number and sustainable payout ratio.
DP17.81%
EPS Next 2Y47.41%
EPS Next 3Y36.67%
EVISO.MI Yearly Income VS Free CF VS DividendEVISO.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 2M 4M
EVISO.MI Dividend Payout.EVISO.MI Dividend Payout, showing the Payout Ratio.EVISO.MI Dividend Payout.PayoutRetained Earnings

More info and screens

EVISO SPA

BIT:EVISO (6/19/2025, 7:00:00 PM)

10.38

+0.04 (+0.39%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners4.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap255.97M
Analysts83.64
Price Target11.19 (7.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP17.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.31%
PT rev (3m)30.56%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.06%
Valuation
Industry RankSector Rank
PE 41.52
Fwd PE 21.67
P/S 0.9
P/FCF 25.9
P/OCF 19.38
P/B 12.8
P/tB 23.88
EV/EBITDA 20.94
EPS(TTM)0.25
EY2.41%
EPS(NY)0.48
Fwd EY4.61%
FCF(TTM)0.4
FCFY3.86%
OCF(TTM)0.54
OCFY5.16%
SpS11.55
BVpS0.81
TBVpS0.43
PEG (NY)0.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 29.92%
ROCE 34.92%
ROIC 24.37%
ROICexc 126.12%
ROICexgc N/A
OM 3.16%
PM (TTM) 2.1%
GM 6%
FCFM 3.47%
ROA(3y)0.8%
ROA(5y)N/A
ROE(3y)3.6%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y114.57%
ROICexc growth 5YN/A
OM growth 3Y6.8%
OM growth 5YN/A
PM growth 3Y7.51%
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5YN/A
F-Score8
Asset Turnover3.24
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 0.9
Debt/EBITDA 0.43
Cap/Depr 129.57%
Cap/Sales 1.17%
Interest Coverage 250
Cash Conversion 114.18%
Profit Quality 165.12%
Current Ratio 1.07
Quick Ratio 1.07
Altman-Z 6.02
F-Score8
WACC8.34%
ROIC/WACC2.92
Cap/Depr(3y)223.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)183.3%
EPS 3Y55.59%
EPS 5YN/A
EPS Q2Q%49.45%
EPS Next Y56.54%
EPS Next 2Y47.41%
EPS Next 3Y36.67%
EPS Next 5YN/A
Revenue 1Y (TTM)51.05%
Revenue growth 3Y43.61%
Revenue growth 5YN/A
Sales Q2Q%55.53%
Revenue Next Year45.79%
Revenue Next 2Y34.22%
Revenue Next 3Y26.97%
Revenue Next 5YN/A
EBIT growth 1Y99.7%
EBIT growth 3Y53.38%
EBIT growth 5YN/A
EBIT Next Year66.9%
EBIT Next 3Y35.49%
EBIT Next 5YN/A
FCF growth 1Y489.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y160.04%
OCF growth 3Y56.28%
OCF growth 5YN/A